Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Bimosiamose disodium

EU orphan designation number: EU/3/05/285   
Active ingredient: Bimosiamose disodium
Indication: Treatment of acute lung injury
Sponsor: Revotar Biopharmaceuticals AG
Neuendorfstrasse 24a, D-16761 Hennigsdorf, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2005 Orphan designation EMEA/OD/006/05 (2005)1664 of 27/05/2005